Is Metro Infusion Center a public or private company?

Metro Infusion Center is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Metro Infusion Center founded?

Metro Infusion Center was founded in 2000. It employs 51 to 100 people.

Where is Metro Infusion Center based?

Metro Infusion Center is headquartered in Joliet, United States, in the North America region.

How does Metro Infusion Center make money?

One revenue line is on record: infusion Therapy Services.

Does Metro Infusion Center have an API?

No public API is recorded for Metro Infusion Center.

Metro Infusion Center company profile: firmographics, business model, customers, competitors

Namestring

Metro Infusion Center

Legal namestring

Metro Infusion Center

Websiteurl

metroinfusioncenter.com

Company typeenum

Private

Founded yearint

2000

Operating statusenum

Operating

Ownership categoryenum

Headcount rangeband

51–100

akta.pro rankint

HeadquartersJoliet, United States

HQ citystring

Joliet

HQ countrystring

United States

HQ regionstring

North America

Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values

outpatient infusion therapy, biologic infusion services, chemotherapy administration, chronic disease infusion, ambulatory infusion care

Industry1 code

1Ambulatory Oncology Centers (Outpatient Chemo/Radiation)

CodeHLAFABAIPrimaryNo

NAICS code1 code

All Other Outpatient Care Centers621498

SIC code1 code

Services-Specialty Outpatient Facilities, Nec8093

Product category

Outpatient Infusion Therapy Services

Social media profiles3 records

GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record

1Infusion Therapy Services

TypeSubscription Recurring

Description

Revenue is generated from providing infusion and injection therapy treatments to patients with chronic conditions. Services are billed to insurance carriers, with the company offering comprehensive insurance support including claim processing, benefits verification, and pharmaceutical rebate identification to minimize patient out-of-pocket costs.

metroinfusioncenter.com

Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components7 values

Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D, Others

Pricing details1 tier

1Insurance-based infusion therapy with financial support

ModelOtherBilling cadencePay-as-you-go

Notes

Pricing varies based on insurance plan coverage. Services cost 53% less than hospital-based infusions. Staff identify pharmaceutical rebates and drug assistance programs to reduce out-of-pocket costs for patients.

metroinfusioncenter.com

GTM typeB2C

B2C

Offering typeServices

Services

Core offering1 text field

Metro Infusion Center is a national outpatient provider of infusion and injection therapy for patients with complex chronic conditions, including infectious diseases, neurological diseases, and multiple sclerosis. Services include chemotherapy, biotherapy, and immunotherapy administered in 200+ U.S. clinics, with clinical pharmacy oversight, pediatric-capable facilities, and insurance/rebate support to reduce patient out-of-pocket cost.

Differentiator

Functional benefit

Problem solved

Quantifiable outcome1 of 2 values shown

53% lower cost compared to hospital-based infusion services

+1 more record

Product overview1 text field

Metro Infusion Center operates as a national outpatient infusion therapy provider offering a coordinated suite of services centered on infusion and injection treatments. The core offering is infusion therapy services for chronic conditions (infectious diseases, neurological diseases, multiple sclerosis) plus chemotherapy, biotherapy, and immunotherapy. Supporting services include pediatric infusion support with specialized rooms and pumps, comprehensive insurance and financial assistance (verification, claims processing, pharmaceutical rebates), and referral coordination programs for both biologic medications and oncology treatments. The company operates 200+ outpatient locations with physician-supervised infusions at costs averaging 53% less than hospital-based care.

Product and service1 record

1Outpatient Infusion and Injection Therapy Services

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners

1Florida Blue / Blue Cross Blue Shield of Florida

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor

Description

Metro Infusion Center now accepts Florida Blue and Blue Cross Blue Shield of Florida patients for infusion therapy services. This partnership expands access to affordable infusion care for insurance beneficiaries in the Florida region.

metroinfusioncenter.com

2Pharmaceutical Rebate Programs (Benlysta, Cimzia, Dalvance, Inflectra, Gamunex, Krystexxa, Nucala, Orencia, Radicava, Remicade, Rituxan/Actemra, Stelara, Simponi, Xolair, Zinplava)

Strategic tierCoreTypeOthers

Description

Metro Infusion Center works with pharmaceutical manufacturers to identify and process pharmaceutical rebates and patient assistance programs for qualifying patients. The company provides links to financial assistance programs for numerous biologic medications including Benlysta, Cimzia, Dalvance, Inflectra, Gamunex, Krystexxa, Nucala, Orencia, Radicava, Remicade, Rituxan/Actemra, Stelara, Simponi, Xolair, and Zinplava.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused

No

API detail

Has APIbool

No

Docs URL, Description

AI maturity

App detail

Has app

Core technology

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →